Related Experiment Video

Updated: Aug 20, 2026

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

PKCdelta is involved in signal attenuation in CD3+ T cells

Thomas Gruber1, Johannes Barsig, Christa Pfeifhofer

  • 1Department of Medical Biology and Human Genetics, Innsbruck Medical University, Schoepfstrasse 41, A-6020 Innsbruck, Austria.

Immunology Letters
|December 9, 2004
PubMed

Insights

Protein kinase C delta (PKCdelta) negatively regulates T cell responses. PKCdelta-deficient mice show increased Interleukin-2 (IL-2) production and T cell proliferation, revealing its role in T cell activation.

Area of Science:

  • Immunology
  • Cell Signaling
  • Molecular Biology

Background:

  • Protein kinase C delta (PKCdelta) is involved in signaling pathways of B cells and mast cells.
  • The role of PKCdelta in T cell function remains largely uncharacterized.

Purpose of the Study:

  • To investigate the physiological function of PKCdelta in CD3+ T cells.
  • To determine the impact of PKCdelta deficiency on T cell-mediated immune responses.

Main Methods:

  • Utilized PKCdelta null mice and wild-type sibling controls.
  • Administered anti-CD3 antibodies in vivo to assess T cell responses.
  • Performed in vitro T cell proliferation assays using allogeneic MHC stimulation.

Main Results:

  • PKCdelta null mice exhibited significantly increased blood plasma IL-2 levels after anti-CD3 antibody administration compared to controls.
  • No significant differences were observed in IL-4, IFN-gamma, TNF-alpha, and IL-6 levels.
  • PKCdelta-deficient CD3+ T cells showed enhanced proliferative responses to allogeneic MHC stimulation in vitro.

Conclusions:

  • PKCdelta plays a previously unrecognized role in the negative regulation of T cell receptor (TCR)-induced IL-2 production.
  • PKCdelta deficiency leads to enhanced T cell proliferation, suggesting its importance in controlling T cell activation.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...